Michael Brian Bell - 13 Dec 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Financial Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Michael Brian Bell
Issuer symbol
GH
Transactions as of
13 Dec 2023
Transactions value $
$0
Form type
4
Filing time
15 Dec 2023, 17:15:26 UTC
Previous filing
19 Sep 2023
Next filing
18 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH STOCK OPTION (RIGHT TO BUY) Award $0 +37,326 $0.000000 37,326 13 Dec 2023 COMMON STOCK 37,326 $28.37 Direct F1
transaction GH RESTRICTED STOCK UNITS Award $0 +24,884 $0.000000 24,884 13 Dec 2023 COMMON STOCK 24,884 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a stock option granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.
F2 This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F3 Not applicable for Restricted Stock Units.